IP Library Granted Patent US 12,514,944
Granted Patent B2
US 12,514,944 · App. 16/908,156 · Granted Jan 6, 2026

Systems and methods for implementing treatment of biological fluids

Inventors: Daniel Church (Danville, CA); Tracey Kirkman (Danville, CA); Marc Stern (Oakland, CA); Hosna Akhlaghpour (Belmont, CA)
A61L2/24A61L2/10G06F3/04817G06F3/0482A61L2202/122A61L2202/14A61L2202/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,514,944
App. No.
16/908,156
Granted
Jan 6, 2026
Kind
B2
Abstract

Disclosed herein are systems and methods for implementing a plurality of graphical user interfaces. In one or more examples, an electronic device can include a display that provides the users with a series of graphical user interfaces, each graphical user interface corresponding to one or more of a plurality steps that a user can engage in to operate the electronic device. The one or more graphical user interfaces can include a visual depiction of what the user should be doing to operate the device at a given time, and can provide the user with information necessary such as processing status and identification information of the material being treated so as to operate the device. In one or more examples, the plurality of graphical user interfaces can place data and information of the screen that corresponds to the physical layout of the electronic device.

Claims (80)

1 . A method, comprising:

at an electronic device configured to treat one or more biological fluids by illumination with an ultraviolet light, wherein the electronic device includes a display and an interface configured to accept one or more inputs from a user of the electronic device:

displaying one or more graphical user interfaces directed to a platform-loading process, wherein the one or more graphical user interfaces are configured to acquire first input data corresponding to applying the platform-loading process to a first treatment chamber, second input data corresponding to applying the platform-loading process to a second treatment chamber, and third input data corresponding to applying the platform-loading process to both the first treatment chamber and the second treatment chamber;

displaying one or more graphical user interfaces directed to a scanning process, wherein the one or more graphical user interfaces are configured to acquire input data corresponding to one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids;

displaying one or more graphical user interfaces directed to a treatment process of the first treatment chamber, the second treatment chamber, or both, wherein the one or more graphical user interfaces are configured to visually represent a status of the treatment process of the one or more biological fluids, wherein the one or more graphical user interfaces configured to visually represent a status of the treatment process comprises a graphical user interface configured to visually represent how much time has elapsed in the treatment process and/or a graphical user interface configured to visually represent how much time is left to go before the treatment process has completed;

displaying one or more graphical user interfaces configured to visually represent an amount of time that has elapsed since a treatment process has completed; and

displaying one or more graphical user interfaces, wherein the one or more graphical user interfaces are configured to alert the user to an error when the elapsed time since the treatment process has completed is greater than a pre-determined threshold, wherein the error indicates a treatment error and wherein the biological fluid(s) should be discarded upon indication of the treatment error.

2 . The method of claim 1 , wherein the electronic device is configured to treat the one or more biological fluids by pathogen inactivation with an ultraviolet light and a pathogen inactivation compound in admixture with the one or more biological fluids.

3 . The method claim 1 , wherein a treatment profile for the treatment of the one or more biological fluids is determined, at least in part, by the one or more identifying information elements of the one or more identifying information fields.

4 . The method of claim 1 , wherein the one or more graphical user interfaces directed to a platform-loading process, the one or more graphical user interfaces directed to a scanning process, and the one or more graphical user interfaces directed to a treatment process are collectively configured to visually guide the user as to an operation of the electronic device.

5 . The method of claim 1 , wherein the method further comprises:

at the electronic device configured to treat one or more biological fluids:

displaying a first graphical user interface, wherein the first graphical user interface includes a first button, wherein the first button corresponds to the platform loading process applied to the first treatment chamber for operating the electronic device, and a second button, wherein the second button corresponds to the platform loading process applied to the second treatment chamber for operating the electronic device;

when either the first button or the second button of the first graphical user interface is selected by the user, displaying a second graphical user interface, wherein the second graphical user interface includes an image that instructs the user to perform the platform-loading process to either the first treatment chamber or the second treatment chamber, respectively, wherein the second graphical user interface instructs the user to perform a scanning process and includes one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids, and wherein the second graphical user interface includes a first button that when selected by the user initiates a treatment process for the one or more biological fluids; and

when the first button of the second graphical user interface is selected by the user, displaying a third graphical user interface, wherein the third graphical user interface includes a first visual panel that-is configured to visually represent a status of the treatment process of the one or more biological fluids.

6 . The method of claim 5 , wherein the first graphical user interface includes a third button, wherein the third button corresponds to the platform-loading process applied to both the first treatment chamber and the second treatment chamber for operating the electronic device.

7 . The method of claim 6 , wherein the method further comprises:

when the third button of the first graphical user interface is selected by the user, displaying a second graphical user interface, wherein the second graphical user interface includes an image that instructs the user to perform the platform-loading process to the first chamber and the second treatment chamber, wherein the second graphical user interface includes one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids, and wherein the second graphical user interface includes a first button that when selected by the user initiates a treatment process for the one or more biological fluids; and

when the first button of the second graphical user interface is selected by the user, displaying a third graphical user interface, wherein the third graphical user interface includes first visual panel that is configured to visually represent a status of the treatment process of the one or more biological fluids.

8 . The method of claim 7 , wherein the first button of the second graphical user interface is selectable by the user when a container with a biological fluid to be treated is detected in the first or the second treatment chamber, and the electronic device detects that the first and the second treatment chambers are in a closed position.

9 . The method of claim 7 , wherein the first visual panel of the third graphical user interface includes a first time indicator, and wherein the first time indicator visually depicts an elapsed time since the treatment process has started.

10 . The method of claim 9 , wherein the method further comprises displaying a fourth graphical user interface, when the elapsed time of the first time indicator of the first visual panel of the third graphical user interface is greater than a pre-determined threshold for completion of a treatment process, and wherein the fourth graphical user interface includes a first visual indicator that corresponds to a first time indicator, and wherein the first time indicator visually depicts an elapsed time since the treatment process of the electronic device has been completed.

11 . The method of claim 10 , wherein the method further comprises displaying a fifth graphical user interface, wherein the fifth graphical user interface is configured to alert the user to an error, if the electronic device determines that an error has occurred during the treatment process.

12 . The method of claim 11 , further comprising: directing the user to discard the one or more biological fluids.

13 . The method of claim 11 , wherein the method further comprises displaying a sixth graphical user interface, wherein the sixth graphical interface includes a first button that when selected allows the user to search an event history of the electronic device, wherein the sixth graphical interface includes a second button that when selected allows the user to configure one or more settings of the electronic device, and wherein the sixth graphical user interface includes a third button that when selected allows the user to initiate the selection of the treatment process.

14 . The method of claim 13 , wherein the sixth graphical interface includes a fourth button that when selected allows the user to view an event history of the electronic device.

15 . The method of claim 13 , wherein if the first button of the sixth graphical user interface is selected, displaying a seventh graphical user interface, wherein the seventh graphical user interface includes one or more treatment event information fields that are filled in by the user, wherein the one or more treatment event information fields are associated with one or more treatment event information elements associated with the treatment of one or more biological fluids, and wherein the seventh graphical user interface includes a first button that when selected by the user performs a search of the event history of the electronic device based on the one or more treatment event information field filled in by the user.

16 . A computing system with an electronic device configured to treat one or more biological fluids by illumination with an ultraviolet light, comprising:

a display;

a user interface configured to receive inputs from a user of the system;

a memory; and

one or more processors,

wherein one or more programs are stored in the memory and configured to be executed by the one or more processors, the one or more programs when executed by the one or more processors cause the one or more processors to:

display one or more graphical user interfaces directed to a platform-loading process, wherein the one or more graphical user interfaces are configured to acquire first input data corresponding to applying the platform-loading process to a first treatment chamber, second input data corresponding to applying the platform-loading process to a second treatment chamber, and third input data corresponding to applying the platform-loading process to both the first treatment chamber and the second treatment chamber;

display one or more graphical user interfaces directed to a scanning process, wherein the one or more graphical user interfaces are configured to acquire input data corresponding to one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids;

display one or more graphical user interfaces directed to a treatment process of the first treatment chamber, the second treatment chamber, or both, wherein the one or more graphical user interfaces are configured to visually represent a status of the treatment process of the one or more biological fluids, wherein the one or more graphical user interfaces configured to visually represent a status of the treatment process comprises a graphical user interface configured to visually represent how much time has elapsed in the treatment process and/or a graphical user interface configured to visually represent how much time is left to go before the treatment process has completed;

display one or more graphical user interfaces configured to visually represent an amount of time that has elapsed since treatment process has completed; and

display one or more graphical user interfaces, wherein the one or more graphical user interfaces are configured to alert the user to an error when the elapsed time since the treatment process has completed is greater than a pre-determined threshold, wherein the error indicates a treatment error and wherein the biological fluid(s) should be discarded upon the indication of the treatment error.

17 . The system of claim 16 , wherein the electronic device is configured to treat the one or more biological fluids by pathogen inactivation with an ultraviolet light and a pathogen inactivation compound in admixture with the one or more biological fluids.

18 . The system of claim 16 , wherein a treatment profile for the treatment of the one or more biological fluids is determined, at least in part, by the one or more identifying information elements of the one or more identifying information fields.

19 . The system of claim 16 , wherein the one or more graphical user interfaces directed to a platform-loading process, the one or more graphical user interfaces directed to a scanning process, and the one or more graphical user interfaces directed to a treatment process are collectively configured to visually guide the user as to an operation of the electronic device.

20 . The system of claim 16 , wherein the one or more processors are further caused to: display a first graphical user interface, wherein the first graphical user interface includes a first button, wherein the first button corresponds to the platform-loading process applied to the first treatment chamber for operating the electronic device, and a second button, wherein the second button corresponds to the platform loading process applied to the second treatment chamber for operating the electronic device;

when either the first button or the second button of the first graphical user interface is selected by the user, display a second graphical user interface, wherein the second graphical user interface includes an image that instructs the user to perform the platform-loading process to either the first treatment chamber or the second treatment chamber, respectively, wherein the second graphical user interface instructs the user to perform a scanning process and includes one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids, and wherein the second graphical user interface includes a first button that when selected by the user initiates a treatment process for the one or more biological fluids; and

when the first button of the second graphical user interface is selected by the user, display a third graphical user interface, wherein the third graphical user interface includes a first visual panel that is configured to visually represent a status of the treatment process of the one or more biological fluids.

21 . The system of claim 20 , wherein the first graphical user interface includes a third button, wherein the third button corresponds to the platform-loading process applied to both the first treatment chamber and the second treatment chamber for operating the electronic device.

22 . The system of claim 21 , wherein the one or more processors are further caused to:

display a second graphical user interface when the third button of the first graphical user interface is selected by the user, wherein the second graphical user interface includes an image that instructs the user to perform the platform-loading process to the first chamber and the second treatment chamber, wherein the second graphical user interface includes one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids, and wherein the second graphical user interface includes a first button that when selected by the user initiates a treatment process for the one or more biological fluids; and

display a third graphical user interface when the first button of the second graphical user interface is selected by the user, wherein the third graphical user interface includes a first visual panel that is configured to visually represent a status of the treatment process of the one or more biological fluids.

23 . The system of claim 22 , wherein the first button of the second graphical user interface is selectable by the user when a container with a biological fluid to be treated is detected in the first or the second treatment chamber, and the electronic device detects that the first and the second treatment chambers are in a closed position.

24 . The system of claim 22 , wherein the first visual panel of the third graphical user interface includes a first time indicator, and wherein the first time indicator visually depicts an elapsed time since the treatment process has started.

25 . The system of claim 24 , wherein the one or more processors are further caused to: display a fourth graphical user interface, when the elapsed time of the first time indicator of the first visual panel of the third graphical user interface is greater than a pre-determined threshold for completion of a treatment process, and wherein the fourth graphical user interface includes a first visual indicator that corresponds to a first time indicator, and wherein the first time indicator visually depicts an elapsed time since the treatment process of the electronic device has been completed.

26 . The system of claim 25 , wherein the one or more processors are further caused to: display a fifth graphical user interface, wherein the fifth graphical user interface is configured to alert the user to an error, if the electronic device determines that an error has occurred during the treatment process.

27 . The system of claim 26 , further comprising: directing the user to discard the one or more biological fluids.

28 . The system of claim 26 , wherein the one or more processors are further caused to: display a sixth graphical user interface, wherein the sixth graphical interface includes a first button that when selected allows the user to search an event history of the electronic device, wherein the sixth graphical interface includes a second button that when selected allows the user to configure one or more settings of the electronic device, and wherein the sixth graphical user interface includes a third button that when selected allows the user to initiate the selection of the treatment process.

29 . The system of claim 28 , wherein the sixth graphical interface includes a fourth button that when selected allows the user to view an event history of the electronic device.

30 . The system of claim 28 , wherein if the first button of the sixth graphical user interface is selected, displaying a seventh graphical user interface, wherein the seventh graphical user interface includes one or more treatment event information fields that are filled in by the user, wherein the one or more treatment event information fields are associated with one or more treatment event information elements associated with the treatment of the one or more biological fluids, and wherein the seventh graphical user interface includes a first button that when selected by the user performs a search of the event history of the electronic device based on the one or more treatment event information field filled in by the user.

31 . A computer readable storage medium storing one or more programs, the one or more programs comprising instructions, which when executed by an electronic device configured to treat one or more biological fluids by illumination with an ultraviolet light, the electronic device comprising a display and a user input interface, cause the device to:

display one or more graphical user interfaces directed to a platform-loading process, wherein the one or more graphical user interfaces are configured to acquire first input data corresponding to applying the platform-loading process to a first treatment chamber, second input data corresponding to applying the platform-loading process to a second treatment chamber, and third input data corresponding to applying the platform-loading process to both the first treatment chamber and the second treatment chamber;

display one or more graphical user interfaces directed to a scanning process, wherein the one or more graphical user interfaces are configured to acquire input data corresponding to one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids;

display one or more graphical user interfaces directed to a treatment process, wherein the one or more graphical user interfaces are configured to visually represent a status of the treatment process of the one or more biological fluids, wherein the one or more graphical user interfaces configured to visually represent a status of the treatment process comprises a graphical user interface configured to visually represent how much time has elapsed in the treatment process and/or a graphical user interface configured to visually represent how much time is left to go before the treatment process has completed;

display one or more graphical user interfaces configured to visually represent an amount of time that has elapsed since a treatment process has completed; and

display one or more graphical user interfaces, wherein the one or more graphical user interfaces are configured to alert the user to an error when the elapsed time since the treatment process has completed is greater than a pre-determined threshold, wherein the error indicates a treatment error and wherein the biological fluid(s) should be discarded upon the indication of the treatment error.

32 . The computer readable storage medium of claim 31 , wherein the electronic device is configured to treat the one or more biological fluids by pathogen inactivation with an ultraviolet light and a pathogen inactivation compound in admixture with the one or more biological fluids.

33 . The computer readable storage medium of claim 31 , wherein a treatment profile for the treatment of the one or more biological fluids is determined, at least in part, by the one or more identifying information elements of the one or more identifying information fields.

34 . The computer readable storage medium of claim 31 , wherein the one or more graphical user interfaces directed to a platform-loading process, the one or more graphical user interfaces directed to a scanning process, and the one or more graphical user interfaces directed to a treatment process are collectively configured to visually guide the user as to an operation of the electronic device.

35 . The computer readable storage medium of claim 31 , wherein the device is further caused to: display a first graphical user interface, wherein the first graphical user interface includes a first button, wherein the first button corresponds to the platform-loading process applied to the first treatment chamber for operating the electronic device, and a second button, wherein the second button corresponds to the platform loading process applied to the second treatment chamber for operating the electronic device;

when either the first button or the second button of the first graphical user interface is selected by the user, display a second graphical user interface, wherein the second graphical user interface includes an image that instructs the user to perform the platform-loading process to either the first treatment chamber or the second treatment chamber respectively, wherein the second graphical user interface instructs the user to perform a scanning process and includes one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids, and wherein the second graphical user interface includes a first button that when selected by the user initiates a treatment process for the one or more biological fluids; and

when the first button of the second graphical user interface is selected by the user, display a third graphical user interface, wherein the third graphical user interface includes a first visual panel that is configured to visually represent a status of the treatment process of the one or more biological fluids.

36 . The computer readable storage medium of claim 35 , wherein the first graphical user interface includes a third button, wherein the third button corresponds to the platform-loading process applied to both the first treatment chamber and the second treatment chamber for operating the electronic device.

37 . The computer readable storage medium of claim 36 , wherein the device is further caused to:

when the third button of the first graphical user interface is selected by the user, display a second graphical user interface, wherein the second graphical user interface includes an image that instructs the user to perform the platform-loading process to the first chamber and the second treatment chamber, wherein the second graphical user interface includes one or more identifying information fields, wherein the one or more identifying information fields are associated with one or more identifying information elements associated with the one or more biological fluids, and wherein the second graphical user interface includes a first button that when selected by the user initiates a treatment process for the one or more biological fluids; and

when the first button of the second graphical user interface is selected by the user, display a third graphical user interface, wherein the third graphical user interface includes a first visual panel that is configured to visually represent a status of the treatment process of the one or more biological fluids.

38 . The computer readable storage medium of claim 37 , wherein the first button of the second graphical user interface is selectable by the user when a container with a biological fluid to be treated is detected in the first or the second treatment chamber, and the electronic device detects that the first and the second treatment chambers are in a closed position.

39 . The computer readable storage medium of claim 37 , wherein the first visual panel of the third graphical user interface includes a first time indicator, and wherein the first time indicator visually depicts an elapsed time since the treatment process has started.

40 . The computer readable storage medium of claim 39 , wherein the method further comprises displaying a fourth graphical user interface, when the elapsed time of the first time indicator of the first visual panel of the third graphical user interface is greater than a pre-determined threshold for completion of a treatment process, and wherein the fourth graphical user interface includes a first visual indicator that corresponds to a first time indicator, and wherein the first time indicator visually depicts an elapsed time since the treatment process of the electronic device has been completed.

41 . The system of claim 40 , wherein the method further comprises displaying a fifth graphical user interface, wherein the fifth graphical user interface is configured to alert the user to an error, if the electronic device determines that an error has occurred during the treatment process.

42 . The computer readable storage medium of claim 41 , further comprising: directing the user to discard the one or more biological fluids.

43 . The computer readable storage medium of claim 41 , wherein the method further comprises displaying a sixth graphical user interface, wherein the sixth graphical interface includes a first button that when selected allows the user to search an event history of the electronic device, wherein the sixth graphical interface includes a second button that when selected allows the user to configure one or more settings of the electronic device, and wherein the sixth graphical user interface includes a third button that when selected allows the user to initiate the selection of the treatment process.

44 . The computer readable storage medium of claim 43 , wherein the sixth graphical interface includes a fourth button that when selected allows the user to view an event history of the electronic device.

45 . The computer readable storage medium of claim 43 , wherein if the first button of the sixth graphical user interface is selected, displaying a seventh graphical user interface, wherein the seventh graphical user interface includes one or more treatment event information fields that are filled in by the user, wherein the one or more treatment event information fields are associated with one or more treatment event information elements associated with the treatment of one or more biological fluids, and wherein the seventh graphical user interface includes a first button that when selected by the user performs a search of the event history of the electronic device based on the one or more treatment event information field filled in by the user.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 20, 2026
From: MIDCAP FUNDING IV TRUST
To: CERUS CORPORATION
Reel/Frame 075583/0598 →
RELEASE OF SECURITY INTEREST Recorded May 20, 2026
From: MIDCAP FINANCIAL TRUST
To: CERUS CORPORATION
Reel/Frame 075610/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2026
From: CHURCH, DANIEL; KIRKMAN, TRACEY; STERN, MARC; AKHLAGHPOUR, HOSNA
To: CERUS CORPORATION
Reel/Frame 073694/0086 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (REVOLVING LOAN) Recorded Aug 29, 2025
From: CERUS CORPORATION
To: MIDCAP FUNDING IV TRUST
Reel/Frame 072727/0854 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (TERM LOAN) Recorded Aug 29, 2025
From: CERUS CORPORATION
To: MIDCAP FINANCIAL TRUST
Reel/Frame 072727/0928 →
Continuity (4)
Provisional Application 63035616 · Jun 5, 2020
Provisional Application 62869542 · Jul 1, 2019
Provisional Application 62865210 · Jun 22, 2019
Related Publication 20200397935A1 · Dec 24, 2020
References Cited (338)
US 5167656A · Lynn · 1992 [cited by applicant]
US 5221608A · Cimino et al. · 1993 [cited by applicant]
US 5288605A · Lin et al. · 1994 [cited by applicant]
US 5399719A · Wollowitz et al. · 1995 [cited by applicant]
US 5405343A · Mohr · 1995 [cited by applicant]
US 5418130A · Platz et al. · 1995 [cited by applicant]
US 5459030A · Lin et al. · 1995 [cited by applicant]
US 5482828A · Lin et al. · 1996 [cited by applicant]
US 5556958A · Carroll · 1996 [cited by applicant]
US 5556993A · Wollowitz · 1996 [cited by applicant]
US 5559250A · Cook · 1996 [cited by applicant]
US 5571082A · Bashikirov · 1996 [cited by applicant]
US 5578736A · Wollowitz · 1996 [cited by applicant]
US 5585503A · Wollowitz · 1996 [cited by applicant]
US 5589462A · Patat · 1996 [cited by applicant]
US 5593823A · Wollowitz et al. · 1997 [cited by applicant]
US 5618662A · Lin et al. · 1997 [cited by applicant]
US 5625079A · Wollowitz et al. · 1997 [cited by applicant]
US 5654443A · Wollowitz · 1997 [cited by applicant]
US 5691132A · Wollowitz et al. · 1997 [cited by applicant]
US 5709991A · Lin et al. · 1998 [cited by applicant]
US 5712085A · Wollowitz · 1998 [cited by applicant]
US 5871900A · Wollowitz · 1999 [cited by applicant]
US 5908742A · Lin et al. · 1999 [cited by applicant]
US 5965349A · Lin · 1999 [cited by applicant]
US 5972593A · Wollowitz · 1999 [cited by applicant]
US 6004741A · Wollowitz · 1999 [cited by applicant]
US 6004742A · Wollowitz · 1999 [cited by applicant]
US 6017691A · Wollowitz et al. · 2000 [cited by applicant]
US 6093725A · Cook et al. · 2000 [cited by applicant]
US 6133460A · Wollowitz et al. · 2000 [cited by applicant]
US 6143490A · Cook et al. · 2000 [cited by applicant]
US 6171777B1 · Cook · 2001 [cited by applicant]
US 6177441B1 · Cook et al. · 2001 [cited by applicant]
US 6194139B1 · Wollowitz · 2001 [cited by applicant]
US 6218100B1 · Wollowitz · 2001 [cited by applicant]
US 6251580B1 · Lin · 2001 [cited by applicant]
US 6270952B1 · Cook et al. · 2001 [cited by applicant]
US 6277337B1 · Goodrich, Jr. et al. · 2001 [cited by applicant]
US 6281225B1 · Hearst et al. · 2001 [cited by applicant]
US 6410219B1 · Cook et al. · 2002 [cited by applicant]
US 6420570B1 · Wollowitz · 2002 [cited by applicant]
US 6433343B1 · Cimino et al. · 2002 [cited by applicant]
US 6455286B1 · Wollowitz · 2002 [cited by applicant]
US 6469052B2 · Wollowitz · 2002 [cited by applicant]
US 6494753B1 · Tomasino · 2002 [cited by applicant]
US 6503699B1 · Wollowitz et al. · 2003 [cited by applicant]
US 6514987B1 · Cook et al. · 2003 [cited by applicant]
US 6544727B1 · Hei · 2003 [cited by applicant]
US 6548242B2 · Horowitz et al. · 2003 [cited by applicant]
US 6565802B1 · Hanley · 2003 [cited by applicant]
US 6586749B2 · Cimino · 2003 [cited by applicant]
US 6686480B2 · Wollowitz · 2004 [cited by applicant]
US 6709810B2 · Cook · 2004 [cited by applicant]
US 6843961B2 · Hlavinka et al. · 2005 [cited by applicant]
US 6949753B2 · Cimino · 2005 [cited by applicant]
US 6951713B2 · Hei et al. · 2005 [cited by applicant]
US 6986867B2 · Hanley et al. · 2006 [cited by applicant]
US 7025877B1 · De Gheldere · 2006 [cited by applicant]
US 7037642B2 · Hei et al. · 2006 [cited by applicant]
US 7105093B2 · De Gheldere · 2006 [cited by applicant]
US 7293985B2 · Cook · 2007 [cited by applicant]
US 7425304B2 · De Gheldere · 2008 [cited by applicant]
US 7433030B2 · Waldo et al. · 2008 [cited by applicant]
US 7459695B2 · Hanley et al. · 2008 [cited by applicant]
US 7601298B2 · Waldo et al. · 2009 [cited by applicant]
US 7611831B2 · Hei · 2009 [cited by applicant]
US 7655392B2 · Stassinopoulos · 2010 [cited by applicant]
US 7788038B2 · Oshita · 2010 [cited by applicant]
US 7829867B2 · Hlavinka et al. · 2010 [cited by applicant]
US 8296071B2 · Edrich et al. · 2012 [cited by applicant]
US 8492162B2 · Kippenhan · 2013 [cited by applicant]
US 8778263B2 · Walker et al. · 2014 [cited by applicant]
US 8900805B2 · Mufti et al. · 2014 [cited by applicant]
US 9259525B2 · Hei · 2016 [cited by applicant]
US 9320817B2 · Walker et al. · 2016 [cited by applicant]
US 9713627B2 · Mufti · 2017 [cited by applicant]
US 10004821B2 · Dobrinsky · 2018 [cited by applicant]
US 10357516B2 · Mufti · 2019 [cited by applicant]
US 10506915B2 · Iwasaki · 2019 [cited by applicant]
US 10758868B2 · Fulkerson · 2020 [cited by applicant]
US 10799533B2 · Corash · 2020 [cited by applicant]
US 10842818B2 · Vermeij · 2020 [cited by applicant]
US 11096963B2 · Corash et al. · 2021 [cited by applicant]
US 11554185B2 · Church et al. · 2023 [cited by applicant]
US 11660365B2 · Thompson · 2023 [cited by applicant]
US 11883544B2 · Church · 2024 [cited by applicant]
US 20010009756A1 · Hei · 2001 [cited by applicant]
US 20010018179A1 · Hei · 2001 [cited by applicant]
US 20020006393A1 · Wollowitz · 2002 [cited by applicant]
US 20020028432A1 · Cook · 2002 [cited by applicant]
US 20020042043A1 · Stassinopoulos · 2002 [cited by applicant]
US 20020115585A1 · Hei · 2002 [cited by applicant]
US 20020192632A1 · Hei · 2002 [cited by applicant]
US 20030035751A1 · Hanley et al. · 2003 [cited by applicant]
US 20030062483A1 · Cimino · 2003 [cited by applicant]
US 20030105339A1 · Wollowitz · 2003 [cited by applicant]
US 20030113704A1 · Stassinopoulos · 2003 [cited by applicant]
US 20030146162A1 · Metzel et al. · 2003 [cited by applicant]
US 20030185804A1 · Wollowitz et al. · 2003 [cited by applicant]
US 20030207247A1 · Stassinopoulos et al. · 2003 [cited by applicant]
US 20030219354A1 · Hlavinka et al. · 2003 [cited by applicant]
US 20040021809A1 · Sumiyoshi et al. · 2004 [cited by applicant]
US 20040029897A1 · Cook · 2004 [cited by applicant]
US 20040088189A1 · Veome et al. · 2004 [cited by applicant]
US 20040172007A1 · Grimm et al. · 2004 [cited by applicant]
US 20040180321A1 · Cook · 2004 [cited by applicant]
US 20040185544A9 · Hei · 2004 [cited by applicant]
US 20040185553A9 · Hei · 2004 [cited by applicant]
US 20040197343A1 · Dubensky et al. · 2004 [cited by applicant]
US 20040228877A1 · Dubensky et al. · 2004 [cited by applicant]
US 20050142542A1 · Hei · 2005 [cited by applicant]
US 20050175625A1 · Jaffee et al. · 2005 [cited by applicant]
US 20050202395A1 · Edrich et al. · 2005 [cited by applicant]
US 20050249748A1 · Dubensky et al. · 2005 [cited by applicant]
US 20050281783A1 · Kinch et al. · 2005 [cited by applicant]
US 20060093999A1 · Hei · 2006 [cited by applicant]
US 20060115466A1 · Stassinopoulos · 2006 [cited by applicant]
US 20060197031A1 · De Gheldere et al. · 2006 [cited by applicant]
US 20060221329A1 · Waldo et al. · 2006 [cited by applicant]
US 20070031457A1 · Dubensky et al. · 2007 [cited by applicant]
US 20070190029A1 · Pardoll et al. · 2007 [cited by applicant]
US 20070190063A1 · Bahjat et al. · 2007 [cited by applicant]
US 20070207170A1 · Dubensky et al. · 2007 [cited by applicant]
US 20070207171A1 · Dubensky et al. · 2007 [cited by applicant]
US 20070235376A1 · Daniel · 2007 [cited by applicant]
US 20090250626A1 · Schlesser et al. · 2009 [cited by applicant]
US 20100133160A1 · Hei · 2010 [cited by applicant]
US 20110286987A1 · Mufti · 2011 [cited by applicant]
US 20120070339A1 · Lawal · 2012 [cited by applicant]
US 20120073614A1 · Otani · 2012 [cited by examiner]
US 20120153783A1 · Shoenfeld · 2012 [cited by applicant]
US 20120313014A1 · Stibich et al. · 2012 [cited by applicant]
US 20130320299A1 · Li · 2013 [cited by applicant]
US 20130323128A1 · Owen et al. · 2013 [cited by applicant]
US 20140303547A1 · Loupis et al. · 2014 [cited by applicant]
US 20140346370A1 · Dobrinsky et al. · 2014 [cited by applicant]
US 20140353519A1 · Wang · 2014 [cited by applicant]
US 20150157665A1 · Mufti · 2015 [cited by applicant]
US 20150299000A1 · Smith et al. · 2015 [cited by applicant]
US 20160354533A1 · Hei · 2016 [cited by applicant]
US 20170014538A1 · Rantala · 2017 [cited by applicant]
US 20170027986A1 · Corash et al. · 2017 [cited by applicant]
US 20170028121A1 · Manzella et al. · 2017 [cited by applicant]
US 20170050046A1 · Walder et al. · 2017 [cited by applicant]
US 20170054687A1 · Ishigaki · 2017 [cited by applicant]
US 20170202882A1 · Vermeij · 2017 [cited by applicant]
US 20170252474A1 · Thompson · 2017 [cited by examiner]
US 20170304363A1 · Corash · 2017 [cited by applicant]
US 20180008639A1 · Mufti · 2018 [cited by applicant]
US 20180113066A1 · Freitag et al. · 2018 [cited by applicant]
US 20180147306A1 · Crawley et al. · 2018 [cited by applicant]
US 20180184985A1 · Håkansson et al. · 2018 [cited by applicant]
US 20180185484A1 · Greenman et al. · 2018 [cited by applicant]
US 20180193500A1 · Safavi et al. · 2018 [cited by applicant]
US 20180289873A1 · David · 2018 [cited by applicant]
US 20180318348A1 · Corash et al. · 2018 [cited by applicant]
US 20180369437A1 · Grossman et al. · 2018 [cited by applicant]
US 20190085289A1 · Greenman · 2019 [cited by applicant]
US 20190099543A1 · Sasaki · 2019 [cited by applicant]
US 20190100718A1 · Estes et al. · 2019 [cited by applicant]
US 20190209718A1 · Church · 2019 [cited by applicant]
US 20190321407A1 · Erickson et al. · 2019 [cited by applicant]
US 20190369087A1 · North et al. · 2019 [cited by applicant]
US 20200078406A1 · Weiner et al. · 2020 [cited by applicant]
US 20200397931A1 · Church et al. · 2020 [cited by applicant]
US 20200405891A1 · Church et al. · 2020 [cited by applicant]
US 20210038802A1 · Madsen · 2021 [cited by applicant]
US 20210052804A1 · Madsen · 2021 [cited by applicant]
US 20210187020A1 · Corash et al. · 2021 [cited by applicant]
US 20210260114A1 · Corash et al. · 2021 [cited by applicant]
US 20210322479A1 · Vermeij · 2021 [cited by applicant]
US 20220031917A1 · Cahyadi et al. · 2022 [cited by applicant]
US 20220118136A1 · Church et al. · 2022 [cited by applicant]
US 20230226232A1 · Church et al. · 2023 [cited by applicant]
US 20240108767A1 · Church · 2024 [cited by applicant]
US 20240350687A1 · Church · 2024 [cited by applicant]
CN 1284886A · 2001 [cited by applicant]
CN 1450916A · 2003 [cited by applicant]
CN 203017432U · 2013 [cited by applicant]
CN 105412960A · 2016 [cited by examiner]
CN 106421864A · 2017 [cited by applicant]
CN 107075478A · 2017 [cited by applicant]
CN 107852359A · 2018 [cited by applicant]
EP 1181061B1 · 2006 [cited by applicant]
EP 3009946A1 · 2016 [cited by applicant]
JP 2006501978A · 2006 [cited by applicant]
JP 2006505349A · 2006 [cited by applicant]
JP 2011036683A · 2011 [cited by applicant]
JP 2015042266A · 2015 [cited by applicant]
JP 2015171440A · 2015 [cited by applicant]
JP 2017029717A · 2017 [cited by applicant]
JP 2017077247A · 2017 [cited by applicant]
JP 2017153966A · 2017 [cited by applicant]
JP 2017184725A · 2017 [cited by applicant]
WO 199300005A1 · 1993 [cited by applicant]
WO 199317553A1 · 1993 [cited by applicant]
WO 199403054A1 · 1994 [cited by applicant]
WO 199420090A1 · 1994 [cited by applicant]
WO 199427433A1 · 1994 [cited by applicant]
WO 199428120A1 · 1994 [cited by applicant]
WO 199500141A1 · 1995 [cited by applicant]
WO 199512973A1 · 1995 [cited by applicant]
WO 199519705A1 · 1995 [cited by applicant]
WO 199608965A1 · 1996 [cited by applicant]
WO 199614737A1 · 1996 [cited by applicant]
WO 199614739A1 · 1996 [cited by applicant]
WO 199614740A1 · 1996 [cited by applicant]
WO 199639815A1 · 1996 [cited by applicant]
WO 199639818A1 · 1996 [cited by applicant]
WO 199639820A1 · 1996 [cited by applicant]
WO 199640857A1 · 1996 [cited by applicant]
WO 199721346A1 · 1997 [cited by applicant]
WO 199737536A1 · 1997 [cited by applicant]
WO 199818908A1 · 1998 [cited by applicant]
WO 199830327A1 · 1998 [cited by applicant]
WO 199830545A1 · 1998 [cited by applicant]
WO 199903976A2 · 1999 [cited by applicant]
WO 199903976A3 · 1999 [cited by applicant]
WO 199926476A1 · 1999 [cited by applicant]
WO 199934839A1 · 1999 [cited by applicant]
WO 199934914A1 · 1999 [cited by applicant]
WO 199934915A1 · 1999 [cited by applicant]
WO 199959645A1 · 1999 [cited by applicant]
WO 199963981A2 · 1999 [cited by applicant]
WO 199963981A3 · 2000 [cited by applicant]
WO 200074731A1 · 2000 [cited by applicant]
WO 200191775A2 · 2001 [cited by applicant]
WO 200191775A3 · 2002 [cited by applicant]
WO 02053209A1 · 2002 [cited by applicant]
WO 2003047650A2 · 2003 [cited by applicant]
WO 2003049784A2 · 2003 [cited by applicant]
WO 2003049784A3 · 2003 [cited by applicant]
WO 2003061379A2 · 2003 [cited by applicant]
WO 2003065787A2 · 2003 [cited by applicant]
WO 2003078023A1 · 2003 [cited by applicant]
WO 2003061379A3 · 2003 [cited by applicant]
WO 2003090794A1 · 2003 [cited by applicant]
WO 2003065787A3 · 2003 [cited by applicant]
WO 2003047650A3 · 2004 [cited by applicant]
WO 2004018471A1 · 2004 [cited by applicant]
WO WO2004033081A2 · 2004 [cited by examiner]
WO 2004044810A1 · 2004 [cited by applicant]
WO 2004033081A3 · 2004 [cited by applicant]
WO 2004049914A2 · 2004 [cited by applicant]
WO 2004050029A2 · 2004 [cited by applicant]
WO 2004050848A2 · 2004 [cited by applicant]
WO 2004050897A2 · 2004 [cited by applicant]
WO 2004050897A3 · 2004 [cited by applicant]
WO 2004050029A3 · 2004 [cited by applicant]
WO 2004084936A2 · 2004 [cited by applicant]
WO 2004050848A3 · 2004 [cited by applicant]
WO 2004110481A2 · 2004 [cited by applicant]
WO 2004049914A3 · 2005 [cited by applicant]
WO 2005009463A2 · 2005 [cited by applicant]
WO 2004110481A3 · 2005 [cited by applicant]
WO 2005037233A2 · 2005 [cited by applicant]
WO 2004084936A3 · 2005 [cited by applicant]
WO 2005009463A3 · 2005 [cited by applicant]
WO 2005067460A2 · 2005 [cited by applicant]
WO 2005071088A2 · 2005 [cited by applicant]
WO 2005092372A2 · 2005 [cited by applicant]
WO 2005071088A3 · 2005 [cited by applicant]
WO 2005037233A3 · 2006 [cited by applicant]
WO 2006021314A2 · 2006 [cited by applicant]
WO 2006050328A1 · 2006 [cited by applicant]
WO 2005092372A3 · 2006 [cited by applicant]
WO 2005067460A3 · 2006 [cited by applicant]
WO 2007022511A2 · 2007 [cited by applicant]
WO 2007022520A2 · 2007 [cited by applicant]
WO 2007022520A3 · 2007 [cited by applicant]
WO 2007022511A3 · 2007 [cited by applicant]
WO 2007103225A2 · 2007 [cited by applicant]
WO 2007103261A2 · 2007 [cited by applicant]
WO 2007117371A2 · 2007 [cited by applicant]
WO 2007103225A3 · 2008 [cited by applicant]
WO 2007103261A3 · 2008 [cited by applicant]
WO 2007117371A3 · 2008 [cited by applicant]
WO 2008156813A1 · 2008 [cited by applicant]
WO 2009126786A2 · 2009 [cited by applicant]
WO 2009126786A3 · 2010 [cited by applicant]
WO 2011120172A1 · 2011 [cited by applicant]
WO 2012018484A2 · 2012 [cited by applicant]
WO 2012018484A3 · 2012 [cited by applicant]
WO 2012071135A2 · 2012 [cited by applicant]
WO 2012071135A3 · 2012 [cited by applicant]
WO WO2014022717A1 · 2014 [cited by examiner]
WO 2014051882A1 · 2014 [cited by applicant]
WO 2014051906A1 · 2014 [cited by applicant]
WO WO2015168783A1 · 2015 [cited by examiner]
WO 2016014854A1 · 2016 [cited by applicant]
WO 2016057965A1 · 2016 [cited by applicant]
WO 2016115535A1 · 2016 [cited by applicant]
WO 2016149055A2 · 2016 [cited by applicant]
WO 2016149055A3 · 2016 [cited by applicant]
WO 2016210374A1 · 2016 [cited by applicant]
WO 2017009534A1 · 2017 [cited by applicant]
WO 2017047119A1 · 2017 [cited by applicant]
WO 2017062260A2 · 2017 [cited by applicant]
WO 2017062260A3 · 2017 [cited by applicant]
WO 2017070619A1 · 2017 [cited by applicant]
WO 2017120545A2 · 2017 [cited by applicant]
WO 2017120545A3 · 2017 [cited by applicant]
WO 2018119462A1 · 2018 [cited by applicant]
WO 2018125994A1 · 2018 [cited by applicant]
WO 2018161020A1 · 2018 [cited by applicant]
WO 2019060610A1 · 2019 [cited by applicant]
WO 2019133929A1 · 2019 [cited by applicant]
WO 2020061537A1 · 2020 [cited by applicant]
WO 2020263759A2 · 2020 [cited by applicant]
WO 2020264421A1 · 2020 [cited by applicant]
WO 2020263759A3 · 2021 [cited by applicant]
WO 2022087580A1 · 2022 [cited by applicant]
CN 105412960 A_translation. [cited by examiner]
Alhumaidan, H. et al. (2012). “Current Status of Additive Solution for Platelets,” J. Clin Apheresis 27:93-98. [cited by applicant]
International Preliminary Report on Patentability, issued Dec. 28, 2021, for PCT Application No. PCT/US2020/039011, filed Jun. 22, 2020, 13 pages. [cited by applicant]
International Preliminary Report on Patentability, issued Dec. 28, 2021, for PCT Application No. PCT/US2020/039984, filed Jun. 26, 2020, 8 pages. [cited by applicant]
International Preliminary Report on Patentability, issued Jun. 30, 2020, for PCT Application No. PCT/US2018/068048, 11 pages. [cited by applicant]
International Preliminary Report on Patentability, issued mailed Dec. 28, 2021, for PCT Application No. PCT/US2020/038950, filed Jun. 22, 2020, 9 pages. [cited by applicant]
International Search Report and Written Opinion, mailed Aug. 19, 2002, for PCT Application No. PCT/US2020/038950, filed Jun. 22, 2020, 16 pages. [cited by applicant]
International Search Report and Written Opinion, mailed Dec. 23, 2020, for PCT Application No. PCT/US2020/039011, filed Jun. 22, 2020, 18 pages. [cited by applicant]
International Search Report and Written Opinion, mailed Jan. 17, 2022, for PCT Application No. PCT/US2021/0071920, filed Oct. 18, 2021, 14 pages. [cited by applicant]
International Search Report and Written Opinion, mailed May 3, 2019, for PCT Application No. PCT/US2018/068048, filed on Dec. 28, 2018 18 pages. [cited by applicant]
International Search Report and Written Opinion, mailed Sep. 29, 2020, for PCT Application No. PCT/US2020/039984, filed Jun. 26, 2020, 14 pages. [cited by applicant]
Irsch, J. et al. (2011, e-pub. Jan. 27, 2011). “Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the Intercept Blood System™,” Transfus. Med. Hemother. 38:19-31. [cited by applicant]
Prodouz, K.N. et al. (1992). “Effects of Two Viral Inactivation Methods on Platelets: Laser-UV Radiation and Merocyanie 540-Mediated Photoinactivation,” Blood Cells 18(1): 101-116. [cited by applicant]
Prowse, C.V. (Apr. 2013, e-pub. Nov. 8, 2012). “Component Pathogen Inactivation: A Critical Review,” Vox Sanguinis, 104(3):183-199. [cited by applicant]
Reikvam, H. et al. (2010). “The Mirasol® Pathogen Reduction Technology System and Quality of Platelets Stored in Platelet Additive Solution,” Blood Transfus. 8:186-192. [cited by applicant]
Ringwald, J. et al. (Apr. 2006). “The New Generation of Platelet Additivie Solution for Storage at 22° C.: Development and Current Experience,” Transfusion Medicine Reviews, 20(2):158-164. [cited by applicant]
Schlenke, P. (2014, e-pub. Jul. 21, 2014). “Pathogen Inactivation Technologies for Cellular Blood Components: an Update,” Transfus. Med. Hemother. 41:309-325. [cited by applicant]
Schlenke, P. et al. (2008). “Photochemical Treatment of Plasma With Amotosalen and UVA Light: Process Validation in Three European Blood Centers,” Transfusion 48:697-705, 9 pages. [cited by applicant]
Seltsam, A. et al. (2011, e-pub. Jan. 22, 2011). “UVC Irraditation for Pathogen Reduction of Platelet Concentrates and Plasma,” Transfusion Medicine and Hemotherapy 38:43-54. [cited by applicant]
Sofer, G. (Aug. 2002). “Virus Inactivation in the 1990s—and Into the 21st Century: Part 2, Red Blood Cells and Platelets,” BioPharm pp. 42-49. [cited by applicant]
U.S. Appl. No. 09/238,355, Greenman, W. et al, filed Jan. 27, 1999. (Copy not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 2004.). [cited by applicant]
U.S. Appl. No. 17/451,311, Church, D. et al., filed Oct. 18, 2021. (Copy not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 2004.). [cited by applicant]
Anonymous (2018). “DS9900 Series Corded Hybrid Imager for Labs,” Zebra, 4 pages. [cited by applicant]
Oxford English Dictionary (Date Unknown). “System,” located at <https://www.oed.com/search/dictionary/?scope=Entries&q=system&tl=true>, last visited on Sep. 26, 2023, one page. [cited by applicant]
International Preliminary Report on Patentability, issued Apr. 13, 2023 for PCT Application No. PCT/US2021/071920, filed Oct. 18, 2021, 7 pages. [cited by applicant]